A recently reported retrospective longitudinal study found that neuropathological changes in the hypothalamus were similar in magnitude to changes seen in the hippocampus, and that hypothalamic atrophy was associated with AD biomarkers (CSF levels of Aβ42, tau, and phosphorylated-tau) [29]. Here, MAPT is linked to Alzheimer disease.